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This Month in the Journal
Fascioscapulohumeral muscular dystrophy (FSHD) is a
progressive disorder characterized by muscle weakness
and wasting that generally starts in the upper body and
that can be asymmetric. Contractions of a chromosome
4q subtelomeric repeat, called “D4Z4,” cause FSHD, but
the mechanism by which this happens is not fully under-
stood. This month in the Journal, van der Maarel and
Frants give us a window into the complexity of this
problem. It involves two alleles of the 4q subtelomeric
region and a highly homologous repeat on chromosome
10qter, but contractions in only one of these three se-
quences are found in persons with FSHD. It is likely that
the D4Z4 contraction alters the transcriptional control
of other genes and that this leads to the FSHD pheno-
type. There are several models for how this occurs; van
der Maarel and Frants discuss the evidence for each.
Functional Consequences of PRODH, by Bender et al.
(p. 409)
The proline dehydrogenase PRODH catalyzes the first
step in proline degradation, and its encoding gene is
located on chromosome 22q11 in the region deleted in
velocardiofacial/DiGeorge syndrome (VCFS/DGS). Link-
age of schizophrenia to this region has generated interest
that was further fueled by the fact that individuals with
VCFS/DGS are at increased risk of schizophrenia. Some
groups argue that mutations in PRODH that lead to in-
creased proline levels are associated with risk of schizo-
phrenia, but others are not convinced. One difficulty in
studying this association is that the key environment in
which to study the effects of the PRODH variants is
probably in the CNS, but plasma proline levels have been
used as a proxy. To examine PRODH more directly,
Bender et al. expressed 16 missense variants of PRODH
in CHO-K1 cells and measured their functional conse-
quences. Of these alleles, 11 have reductions in PRODH
activity that range from moderate to complete, and, al-
though data are limited, it appears that the severity of
the mutation on PRODH activity may be correlated with
plasma proline levels. The alleles used in this study were
identified in people with hyperprolinemia, in people with
schizophrenia, and in control individuals. A direct cor-
relation between the severity of the mutation and the
phenotype was not found, but the authors find it in-
triguing that three of four alleles associated with schizo-
phrenia had a severe effect on PRODH activity. Perhaps
these direct functional studies will pave the way for more-
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conclusive studies on the association between schizo-
phrenia and PRODH.
Imprinting and Obesity, by Dong et al. (p. 427)
The need to control intrauterine growth is thought to
have given rise to the development of genetic imprinting
in mammals. This is supported by the fact that several
genes involved in growth, such as IGF2, are imprinted.
Some imprinting disorders, including Beckwith-Wiede-
mann and Prader-Willi syndromes, also include altered
growth and body composition in their phenotypes. This
relationship between genetic imprinting and control of
body size and composition, therefore, makes it plausible
that genes involved in common obesity might have a
parent-of-origin effect. Dong et al. performed genome-
wide parent-of-origin linkage analysis that examined
obesity as a discrete trait and as a series of quantitative
traits. Three regions—chromosomes 10p12, 12q24, and
13q32—appear to influence obesity only when trans-
mitted from a specific parent. None of these regions was
known to contain imprinted genes, so, in addition to
their relevance to obesity, this type of study could fa-
cilitate the identification of additional imprinted regions
in the human genome.
Accounting for Decay of Linkage Disequilibrium, by
Stephens and Scheet (p. 449)
The PHASE algorithm has become a popular method for
haplotype inference from unphased genotype data. Ste-
phens and Scheet have updated this algorithm so that it
takes into account locus spacing and the decay of linkage
disequilibrium (LD) with distance. Because LD generally
declines with distance but is sometimes punctuated by
recombination hotspots, their approach uses a flexible
model that allows for either scenario by estimating the
recombination rate in each intermarker interval. Their
new approach outperforms the previous version of
PHASE and other haplotype-inference methods in an
autosomal genotype data set and, to a lesser extent, in
an X chromosome data set. This method can also be
used to impute missing genotypes with a high degree of
accuracy and is available in the PHASE (v.2.1.1) software
package.
FLCN and Spontaneous Pneumothorax, by Painter et
al. (p. 522)
When air is found in the pleural space in the absence of
trauma or lung disease, it is known as “primary sponta-
Am. J. Hum. Genet. 76:i–ii, 2005
ii
neous pneumothorax” (PSP), a condition that results in
collapse of the lung. PSP can occur as part of an inherited
connective tissue disorder, such as Ehlers-Danlos syn-
drome, but it is also reported as an isolated phenotype.
Familial PSP is usually seen as an autosomal dominant
trait with reduced penetrance, and most patients have
emphysemalike changes called “bullae” in their lungs.
Painter et al. made use of this fact to classify individuals
in a family affected with PSP. They were able to do high-
resolution computed tomography on several members of
this family to identify those with bullae, who were then
classified as “affected.” A genome scan implicated a re-
gion on chromosome 17p that contained an interesting
candidate gene, FLCN. This gene, which encodes folli-
culin, is a candidate because it is mutated in Birt-Hogg-
Dube´ (BHD) syndrome, a disorder associated with an
increased risk of PSP. A frameshift mutation in FLCN
was found only in the members of this family who had
bullae. Thus, although PSP in general is considered to
have fairly low penetrance, the penetrance of bullae in
mutation carriers in this family is 100%. Mechanistically,
the gene identification doesn’t tell us much about the
pathogenesis of PSP, because the function of folliculin is
unknown. Clinically, though, this finding could have im-
plications; because renal cancer and benign skin tumors
are part of the BHD phenotype, Painter et al. argue that
the potential for tumors in individuals with PSP needs
to be considered.
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